5 Myalgic Encephalomyelitis Clinical Trials in Newark, DE (2026)

Q: How do I join a clinical trial in Newark?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Newark

NCT07200830Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

This randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of life without decreasing...

Newark, DE1,524 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT05901493Recruiting

Category Learning Retention in Adults With and Without Developmental Language Disorder

Approximately 7% of the population experiences developmental language disorder (DLD), a language disorder with unclear causes. DLD affects communication beyond adolescence and poses challenges for edu...

Newark, DE540 participantsUniversity of Delaware

View Study Details

NCT05172245Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy ("chemo-radiation") in patients ...

Newark, DE46 participantsNational Cancer Institute (NCI)

View Study Details

NCT06189963Recruiting

Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease

The goal of this clinical trial is to test SNK01 in participants with moderate Alzheimer's Disease. The main questions it aims to answer are: 1. Is SNK01 safe and tolerable when administered every 3 ...

Newark, DE36 participantsNKGen Biotech, Inc.

View Study Details

NCT07542301Recruiting

Breathing Patterns in Infants Before and After Extubation

The primary objective of this study is to compare work of breathing indices before and after extubation in intubated premature infants admitted to the Christiana Care Neonatal Intensive Care Unit. The...

Newark, DE30 participantsChristiana Care Health Services

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Newark

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 5 myalgic encephalomyelitis clinical trials recruiting participants in Newark, DE. These studies are seeking a combined 2,176 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology, University of Delaware, National Cancer Institute (NCI) and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Newark — FAQ

Are there myalgic encephalomyelitis clinical trials in Newark?

Yes, there are 5 myalgic encephalomyelitis clinical trials currently recruiting in Newark, DE. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newark?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.

Are clinical trials in Newark free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 5 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov